The annual Cell Series features 4 outstanding programmes: 7th Cell Culture and Bioprocessing, 5th Stem Cell and Regenerative Medicine, 4th Cell and Gene Therapy and Biobanking Congresses. The Cell Series provides a focused networking platform targeting Cell Culture and Cell Line Development and Bioprocessing; Cell and Gene Therapy highlighting CAR T Cell Development; Stem Cell and Regeneration Medicine Development as well as Biobanking.
The 7th Annual Cell Culture and Bioprocessing Congress 2018, presented by Oxford Global, will see attendance from over 350 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions.
During the two day event there will be over 40 presentations, case studies and panel discussions focussing on the key issues in cell line optimisation, 3D cell culture and bioprocessing technologies.
Horizon will be exhibiting at the conference as well as giving a talk.
Don't miss Horizon Product Manager Jamie Freeman present 'Engineering the Next Generation of Biomanufacturing CHO Cells' at 9:30am on Day 2, in the Cell Culture & Downstream Bioprocessing Stream.
Find out more about Horizon's Bioproduction offerings.